查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球鼻测量系统市场 -2023-2030
市场调查报告书
商品编码
1374818

全球鼻测量系统市场 -2023-2030

Global Rhinometry Systems Market -2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

市场动态

克制

与鼻测量系统相关的成本高昂，鼻测量系统的初始投资和维护成本可能很高，这给医疗机构带来了挑战，特别是在发展中地区。这些系统的高成本可能会限制其采用，从而阻碍市场成长。

此外，由于缺乏熟练的专业人员，有效使用鼻测量系统需要训练有素的医疗保健专业人员，他们可以准确地解释从这些设备获得的资料。某些地区技术人员短缺可能会限制市场成长。应努力对医疗保健专业人员进行鼻测量系统的使用和解释方面的培训和教育。

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 按产品类型分類的片段
  • 按应用程式片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 过敏性鼻炎盛行率上升
      • 科技进步的崛起
    • 限制
      • 与设备相关的高成本
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：按产品类型

  • 声学鼻测量法
  • 光学鼻测量法
  • 阻抗鼻测量法

第 8 章：按应用

  • 过敏诊断
  • 鼻部手术
  • 呼吸系统疾病诊断
  • 其他的

第 9 章：最终用户

  • 医院
  • 耳鼻喉科诊所
  • 门诊手术中心
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Happersberger otopront GmbH
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • ECLERIS
  • GM Instruments
  • Homoth Medizinelektronik GmbH & Co
  • Recorders and Medicare
  • ATMOS MedizinTechnik GmbH
  • Sensonics International
  • Piston Medical
  • BioRESEARCH Associates, Inc
  • HealthManagement

第 13 章：附录

简介目录
Product Code: MD7241

Overview

Rhinomanometry, which measures nasal pressure and airflow during breathing, is accepted as the standard technique for measuring nasal airway resistance and assessing the patency of the nose. Acoustic rhinometry uses a reflected sound signal to measure the cross-sectional area and volume of the nasal passage.

Rhinomanometry is useful to improve patient selection for surgery, distinguish between structural and functional causes of nasal obstruction, diagnose nasal valve collapse, clarify conflicting symptoms and exam findings, use as a medicolegal tool and in nasal allergen challenges.

Market Dynamics: Drivers and Restraints

Rise in the prevalence of allergic rhinitis

The rise in the prevalence of allergic rhinitis is one of the significant key factors that drive the rhinometry systems market during the forecast period. For instance, according to the article published in the National Library of Medicine 2023, the prevalence of allergic rhinitis cases ranged from 1.83 to 9.23% between 2017 and 2022. There was a significant drop of 21.38 to 70.22% between the pre- and post-COVID-19 pandemic. Males were more prevalent in the 6 to 18-year-olds than females. Thus, the above factors help to drive market growth during the forecast period.

Furthermore, the global rhinometry systems market is also driven by various factors like technological advancements in rhinometry, a rise in the prevalence of nasal disorders, a rise in non-invasive diagnostic techniques and others that will drive the market growth during the forecast period.

Market Dynamics: Restraint

High costs associated with rhinometry systems, the initial investment and maintenance costs of rhinometry systems can be substantial, posing a challenge for healthcare facilities, particularly in developing regions. The high costs associated with these systems may limit their adoption, hindering market growth.

Also, lack of skilled professionals the effective use of rhinometry systems requires trained healthcare professionals who can accurately interpret the data obtained from these devices. The shortage of skilled personnel in certain regions may pose a restraint to market growth. Efforts should be made to train and educate healthcare professionals on the usage and interpretation of rhinometry systems.

Segment Analysis

The global rhinometry systems is segmented based on product type, application, end-user and region.

The acoustic rhinometry from the product type segment accounted for approximately 41.2% of the market share

The acoustic rhinometry from the product type segment accounted for 41.2% and it is expected to be dominated during the forecast period. Acoustic rhinometry is a new technique which evaluates nasal obstruction by analysing reflections of a sound pulse introduced via the nostrils. The technique is rapid, reproducible, non-invasive and requires minimal cooperation from the subject. Unlike rhinomanometry, it does not require airflow. A graph of the nasal cross-sectional area as a function of distance from the nostril is produced, from which several area and volume estimates of the nasal cavity can be derived.

The role of acoustic rhinometry in diagnosis is quantifying nasal obstruction. This procedure is particularly important with secondary rhinoplasty patients whose complaints include substantial functional problems in addition to aesthetic concerns.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to be attributed to well-established healthcare infrastructure, rising prevalence of septal deviation, and technological advancements in rhinometry systems in the region. In terms of revenue.

For instance, in March 2020, GM Instruments stated that an exclusive distribution partnership with BioResearch Associates Inc. This partnership supports the North American market expansion into the dental/dental sleep market with a reputable partner experienced in innovative ENT products.

Alongside our distribution partner, we are implementing a collaborative, interdisciplinary approach to patient care and outcomes with a network of dentists and ENTs. There is a need for healthcare policy financial considerations and if 20% of the patients undergoing unnecessary septal surgical intervention were identified pre-operatively then potentially 12 million pounds could be saved with an additional significant reduction in the number of NHS hospital bed days wasted.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the healthcare industry, including the rhinometry systems market. The pandemic has highlighted the importance of non-invasive diagnostic techniques, remote monitoring, and telemedicine. Rhinometry systems, with their non-invasive nature and potential for remote patient care, have gained prominence during the pandemic.

Competitive Landscape

The major global players in the rhinometry systems market include Happersberger otopront GmbH , ECLERIS, GM Instruments, Homoth Medizinelektronik GmbH & Co, Recorders and Medicare, ATMOS MedizinTechnik GmbH , Sensonics International , Piston Medical, BioRESEARCH Associates, Inc, HealthManagement and among others.

Key Developments

  • In June 2022, Vivos Therapeutics signed an exclusive distribution agreement with GM Instruments for the NR6 Rhinomanometer, an FDA-approved device used to measure nasal airway resistance, for treating dentofacial abnormalities and OSA in adults.

Why Purchase the Report?

  • To visualize the global rhinometry systems market segmentation-based product type, application, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of rhinometry systems market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global rhinometry systems market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. Rise in the prevalence of allergic rhinitis
      • 4.1.1.2. Rise in the technology advancements
    • 4.1.2. Restraints
      • 4.1.2.1. High cost associated with the equipment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Acoustic Rhinometry *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Optical Rhinometry
  • 7.4. Impedance Rhinometry

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Allergy Diagnosis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Nasal Surgery
  • 8.4. Respiratory Disease Diagnosis
  • 8.5. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. ENT Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.5.1. Brazil
      • 10.4.5.2. Argentina
      • 10.4.5.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.5.1. China
      • 10.5.5.2. India
      • 10.5.5.3. Japan
      • 10.5.5.4. Australia
      • 10.5.5.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Happersberger otopront GmbH
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. ECLERIS
  • 12.3. GM Instruments
  • 12.4. Homoth Medizinelektronik GmbH & Co
  • 12.5. Recorders and Medicare
  • 12.6. ATMOS MedizinTechnik GmbH
  • 12.7. Sensonics International
  • 12.8. Piston Medical
  • 12.9. BioRESEARCH Associates, Inc
  • 12.10. HealthManagement

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us